Close

Sign in
Sign up

Menu

Intel
Data search
Signals
Startup Concierge
Get intel

Home
News
Atai Life Sciences announced securing $125 million in series c funding.

Atai Life Sciences announced securing $125 million in series c funding.

AI (big data) Biotech Health services Software Services

Germany

Malta

United States

Investments

30 October 2020

Share:

Atai Life Sciences (company)

Germany

AI (big data) Biotech Health services Software Services

Total investments received (USD): 380.1m

Round value (USD): 125m

Round investors: Apeiron Investment Group Galaxy Digital What If Ventures

Company: Atai Life Sciences

Industry: AI (big data) Biotech Health services Software Services

Related deals

Atai Life Sciences raised $157 million in a Series D financing round led by founder Christian Angermayer and Thiel Capital,

AI (big data) Biotech Health services Software Services

Germany

Malta

United States

Switzerland

Investments 03 March 2021

Sidebar

Verticals

Financial Services
Food Industry
Education
E-commerce
Health services
Marketplace

Benelux

Belgium
Netherlands

DACH

Austria
Germany
Switzerland

Nordics and Baltics

Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden

Western Europe

France
Ireland
Italy
Portugal
Spain
United Kingdom

About
Contact
Terms of service
Privacy policy

© All rights reserved Nordic 9 2016-2026. Made with in Stockholm

Top